Histologic findings in pigment dispersion syndrome and pigmentary glaucoma

Journal of Glaucoma

Volumn 15, Issue 2, 2006, Pages 142-151

  Gottanka, Johannes ^a   Johnson, Douglas H ^b   Grehn, Franz ^c   Lütjen Drecoll, Elke ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MAYO CLINIC   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Extracellular material; Pigment dispersion syndrome; Pigmentary glaucoma; Trabecular cell loss; Trabecular meshwork

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT; CELL DAMAGE; CELL GRANULE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; FEMALE; GLAUCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERTRABECULAR SPACE COLLAPSE; INTRAOCULAR HYPERTENSION; MEMBRANE FUSION; MICROSCOPY; NERVE FIBER DEGENERATION; OCCLUSION; PIGMENT DISPERSION SYNDROME; PIGMENT GLAUCOMA; PIGMENT GRANULE; PIGMENTATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCHLEMM CANAL; TISSUE DISTRIBUTION; TRABACULAR LAMELLAE FUSION; TRABECULAR CELL LOSS; TRABECULAR MESHWORK; TRABECULECTOMY;

ADULT; AGED; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; TRABECULAR MESHWORK; TRABECULECTOMY;

EID: 33646791855     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200604000-00011     Document Type: Article

References (36)

1. Sugar HS, Barbour FA. Pigmentary glaucoma: a rare clinical entity. Am J Ophthalmol. 1949;32:90-92.
2. Bick MW. Pigmentary glaucoma in females. Arch Ophthalmol. 1957;58:483-494.
3. Scheie HG, Fleischhauer HW. Idiopathic atrophy of the epithelial layers of the iris and ciliary body: a clinical study. Arch Ophthalmol. 1958;59:216-228.
4. Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol. 1979;97:1667-1672.
5. Campbell DG, Schertzer RM. Pigmentary glaucoma. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. 2nd ed. St. Louis, MO: Mosby-Year Book; 1996.
6. Karickhoff JR. Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg. 1992;23:269-277.
7. Kupfer C, Kuwabara T, Kaiser-Kupfer M. The histopathology of pigmentary dispersion syndrome with glaucoma. Am J Ophthalmol. 1975;80:857-862.
8. Richter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma, a prospective study of the natural history. Arch Ophthalmol. 1986;104:211-215.
9. Farrar SM, Shields MB, Miller KN, et al. Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome. Am J Ophthalmol. 1989;108:223-229.
10. Migliazzo CV, Shaffer RN, Nykin R, et al. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1986;93:1528-1536.
11. Siddiqui Y, Ten Hulzen RD, Cameron JD, et al. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135:794-799.
12. Epstein DL, Freddo TF, Anderson PJ, et al. Experimental obstruction to aqueous outflow by pigment particles in living monkeys. Invest Ophthalmol Vis Sci. 1986;27:387-395.
13. Rohen JW, van der Zypen E. The phagocytic activity of the trabecular meshwork endothelium: an electron microscopic study of the vervet. Albrecht v Graefes Arch Klin Exp Ophthalmol. 1968;175:143-160.
14. Matsumoto Y, Johnson DH. Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest Ophthalmol Vis Sci. 1997;38:1902-1907.
15. Matsumoto Y, Johnson DH. Trabecular meshwork phagocytosis in glaucomatous eyes. Ophthalmologica. 1997;211:147-152.
16. Buller C, Johnson DH, Tschumper RC. Human trabecular meshwork phagocytosis: observations in an organ culture system. Invest Ophthalmol Vis Sci. 1990;31:2156-2163.
17. Rodrigues MM, Spaeth GL, Weinreb S, et al. Spectrum of trabecular pigmentation in open-angle glaucoma: a clinicopathologic study. Trans Am Acad Ophthalmol Otolaryngol. 1976;81:258-276.
18. Richardson TM, Hutchinson BT, Grant WM. The outflow tract in pigmentary glaucoma: a light and electron microscopic study. Arch Ophthalmol. 1977;95:1015-1025.
19. Benedikt O, Roll P. Elektronenmikroskopische Untersuchungen des Trabekelwerkes bei Pigmentglaukom. Klin Monatsbl Augenheilkd. 1980;176:122-130.
20. Robinson CH Jr, Nopaitaya W, McPherson SD Jr. Pigmentary glaucoma: an ultrastructural study. Ann Ophthalmol. 1981;13:49-51.
21. Shimizu T, Hara K, Futa R. Fine structure of trabecular meshwork and iris in pigmentary glaucoma. Graefes Arch Klein Ophthalmol. 1981;215:171-180.
22. Haddad R, Strasser G, Heilig P, et al. Decompensation of chronic open-angle glaucoma following mydriasis-induced pigmentary dispersion into the aqueous humor: a light and electron microscopic study. Br J Ophthalmol. 1981;65:252-257.
23. Richardson TM. Pigmentary glaucoma. In: Ritch R, Shields MB, eds. The Secondary Glaucomas. St. Louis, MO: CV Mosby; 1982:84-98.
24. Alvarado JA, Murphy CG. Outflow obstruction in pigmentary and primary open angle glaucoma. Arch Ophthalmol. 1992;110:1769-1778.
25. Murphy CG, Johnson M, Alvarado JA. Juxtacanalicular tissue in pigmentary and primary open angle glaucoma: the hydrodynamic role of pigment and other constituents. Arch Ophthalmol. 1992;110:1779-1785.
26. Gottanka J, Johnson DH, Martus P, et al. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J Glaucoma. 1997;6:123-132.
27. Rohen JW. Why is intraocular pressure elevated in glaucoma? Ophthalmology. 1983;90:758-765.
28. Gottanka J, Flügel-Koch C, Martus P, et al. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 1997;38:2435-2446.
29. Gottanka J, Johnson DH, Martus P, et al. Beta-adrenergic blocker therapy and the trabecular meshwork. Graefes Arch Clin Exp Ophthalmol. 2001;239:138-144.
30. Johnson D, Gottanka J, Flügel C, et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997;115:375-383.
31. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human: III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100:135-146.
32. Johnson DH, Richardson TM, Epstein DL. Trabecular meshwork recovery after phagocytic challenge. Curr Eye Res. 1989;8:1121-1130.
33. Bárány EH, Linnér E, Lütjen-Drecoll E, et al. Structural and functional effects of trabeculectomy in cynomolgus monkeys. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1972;184:1-28.
34. Johnson DH, Matsumoto Y. Schlemm's canal becomes smaller after successful filtration surgery. Arch Ophthalmol. 2000;118:1251-1256.
35. Schlötzer-Schrehardt U, Naumann GOH. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma: a morphometric, ultrastructural study. Invest Ophthalmol Vis Sci. 1995;36:1750-1764.
36. Hann CR, Bahler CK, Johnson DH. Cationic ferritin and segmental flow through the trabecular meshwork. Invest Ophthalmol Vis Sci. 2005;46:1-7.